Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 451 - 500 out of 7,730

Document Document Title
WO/2015/055447A1
The present invention relates to a process for preparing substituted isatoic acid anhydride compounds of the formula (I) in which R1 is Cl, Br, I, or CN; and R2 is CH3, Cl, Br; using anthranilic acid derivative compounds of formula (III)...  
WO/2015/054476A1
Methods of halogenating a carbon containing compound having an sp3 C-H bond are provided. Methods of fluorinating a carbon containing compound comprising halogenation with Cl or Br followed by nucleophilic substitution with F are provide...  
WO/2015/039172A1
The present invention relates to novel compounds and their use in the prophylactic and/or therapeutic treatment of hypertension and/or fibrosis.  
WO/2015/036550A1
The invention relates to an improved process and novel intermediates (4) and (6) for the preparation of pharmaceutically active compound etoricoxib of formula (1).  
WO/2015/037460A1
Optically active 3-(biphenyl-4-yl)-2-[(t-butoxycarbonyl)amino]propan-1-ol can be produced through: a step of reacting an optically active biphenylalanine compound represented by formula [I] with a reducing agent to produce an optically a...  
WO/2015/032939A1
A solid catalyst component for the polymerization of olefins comprising Mg, Ti and an electron donor of formula (I), where R1 is selected from C1-C15 hydrocarbon groups, R2 groups, equal to or different from each other, are hydrogen or R...  
WO/2015/032357A1
Zanamivir, a Zanamivir intermediate compound (formula 2), and a preparation method therefor. The preparation method is method 1 or 2. Method 1 comprises the following steps: compound 3 undergoes a reaction to remove a protecting group so...  
WO/2015/030106A1
The present invention relates to compounds represented by general formula (I) (where Z, R, Ra, R', * and n are each as defined in the description) or salts thereof.  
WO/2015/025960A1
Provided are: a compound having high activity against harmful organisms; a harmful organism control agent comprising the compound; and a method for controlling harmful organisms by applying the compound. A phenoxyalkylbenzamide-type comp...  
WO/2015/025773A1
This method for producing an m-xylylene diisocyanate contains: a reaction step for generating a bisamide compound by reacting, in the presence of an acidic liquid, a monohalogenated benzene, formaldehyde, and an amide compound indicated ...  
WO/2015/025826A1
The purpose of the present invention is to provide: a novel substituted phenyl ether compound which has a control effect against pests; and a pest control agent which contains this substituted phenyl ether compound as an active ingredien...  
WO/2015/024991A1
The invention relates to a novel synthesis route towards R- biphenylalaninol and to the intermediates applied in this synthesis route. The process according to the invention and the intermediate compounds are useful in the synthesis of p...  
WO/2015/016263A1
The present invention relates to a reaction method having a step for supplying a liquid including at least one species of a raw material compound and a low-boiling compound having a standard boiling point lower than the standard boiling ...  
WO/2015/010436A1
Disclosed is a new Carfilzomib intermediate and a preparation method therefor, and a preparation method for Carfilzomib using the intermediate. The Carfilzomib intermediate provided by the invention is easily separated from the isomers t...  
WO/2015/012407A1
The present invention pertains to a cellulose acylate film containing a compound having at least one linking group selected from the group consisting of a bivalent linking group represented by -NH-(C=O)-O- and a bivalent linking group re...  
WO/2015/012258A1
A composition including: a polymerizable compound (A) having a (meth) acryloyl group and an isocyanate group in each molecule; and a reaction accelerator (B) comprising a compound having a (meth) acryloyl group and a carbamoyl halide gro...  
WO/2015/012259A1
Provided is a reaction accelerator used in a reaction between a compound having an isocyanate group that does not directly bond to an aromatic ring, in each molecule, and a compound having an active hydrogren-containing group. The reacti...  
WO/2015/010014A1
The present invention relates to a method for treating or preventing obesity in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds. The invention further r...  
WO/2015/007897A1
The present invention provides a very simple, efficient and economic technology for racemisation of amines, alcohols or thioalcohols where the chiral carbon (benzylic position) is located at the β-position of the heteroatom (amino, hydr...  
WO/2015/006685A1
The present invention relates to a method for promoting cessation or reduction in the smoking and/or chewing of tobacco or nicotine-containing products in a subject in need thereof, comprising administering to the subject an effective am...  
WO/2014/207071A1
The present invention relates to novel strobilurine type compounds, to compositions comprising at least one such compound, to methods for combating phytopathogenic fungi, to the use of such compounds and to seeds coated with at least one...  
WO/2014/202703A1
The present invention relates to novel strobilurine type compounds I, processes for preparing these compounds, a use of compounds of the formula I and/or their agriculturally useful salts for controlling phytopathogenic fungi, to composi...  
WO/2014/200094A1
[Problem] To provide a novel production method for a stereoselective, optically active alcohol compound. [Solution] From the compound represented by formula (3), the optically active alcohol compound represented by formula (8) can be pro...  
WO/2014/185856A1
The present invention relates to functionalized cyclic carbonates, urethanes and polyurethanes, their methods of production and uses thereof.  
WO/2014/183221A1
Resveratrol analogs and their use to inhibit Kv1.5 channels are provided. The resveratrol analogs are useful in the treatment of atrial arrhythmias, including atrial fibrillation (AF). Exemplary resveratrol analogs are compounds of gener...  
WO/2014/184116A1
The invention relates to new carbodiimides having terminal urea and/or urethane groups of formula (I), wherein R can be the same or different and is selected from the group of the -NHCONHR', -NHCONR'R'', and -NHCOOR''' residues. The inve...  
WO/2014/179859A2
A polymorphic form APO-I of Ezogabine, processes for the preparation thereof and pharmaceutical formulations comprising the polymorphic form APO-I are provided.  
WO/2014/164969A1
The present invention relates to a method of treating cataplexy in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds.  
WO/2014/163016A1
This xylylene dicarbamate contains impurities represented by formulas (1)-(4) in a ratio such that the total thereof constitutes less than 100ppm on a mass basis. (In formulas (1)-(4), R represents a monovalent hydrocarbon group.)  
WO/2014/157653A1
The present invention addresses the problem of providing an efficient process for preparing important intermediate compounds (1) and (1a) for the production of FXa inhibitors (X) and (X-a). The present invention pertains to: a process wh...  
WO/2014/155264A1
The present invention provides an improved and commercial process for the preparation of Lacosamide having formula (I). Further, the present invention also provides the novel intermediate compounds of formula (VI) and (VII) and their pro...  
WO/2014/157636A1
A method for producing isocyanate, said method comprising: a carbamation step for producing an N-substituted carbamate by a carbamation reaction using an organic primary amine, urea and an organic hydroxy compound, and then collecting fi...  
WO/2014/153147A1
Disclosed are compounds of the general formula I and II (as further defined herein) are useful in the production of inhibitors of sphingolipid synthesis the production of sphingolipids. Suitable sphingolipids, include, but not limited to...  
WO/2014/151363A1
Addition- fragmentation agents having the following functional groups: 1) a labile addition- fragmentation group that can cleave and reform to relieve strain, 2) at least one high refractive index group, and 3) at least one ethylenically...  
WO/2014/141578A1
The present invention is a symmetrical hyperbranched silicone-modified polymerizable compound which includes a compound represented by general formula (1). As a result, a positionally and sterically symmetrical hyperbranched silicone-mod...  
WO/2014/142547A1
The present invention relates to a composition for neuroprotection comprising a phenyl carbamate compound and a method for providing neuroprotection therewith. The present invention ensures the enhancement of neuroprotection, such that i...  
WO/2014/142548A1
The present invention relates to a composition for preventing or treating a nerve gas-induced disease comprising a phenyl carbamate compound and a method for preventing or treating a nerve gas-induced disease therewith. The present inven...  
WO/2013/100571A9
A composition for treating and/or preventing ALS containing the phenyl carbamate compound or a pharmaceutically acceptable salt thereof as an active ingredient; a method of treating and/or preventing ALS comprising administering the phen...  
WO/2014/142549A1
The present invention relates to a composition for preventing or treating a memory loss related disease comprising a phenyl carbamate compound and a method for preventing or treating various diseases related to loss of memory therewith. ...  
WO/2014/142550A1
The present invention relates to a composition for preventing or treating a psychiatric disorder comprising a phenyl carbamate compound and a method for preventing or treating a psychiatric disorder therewith. The present invention provi...  
WO/2014/135728A1
The invention relates to compounds of formula R1-O-CO-NH-X-NH-CO-O-R2 (I), in which R1 and R2 are, independently, 2-ethylhexanol, polyethylene glycol having a molecular weight of between 200 and 600 or monomethyl ether of polyethylene gl...  
WO/2014/136731A1
A composition characterized by containing the following: a compound (A) that is provided with a substituent or substituents (a), namely an acryloyl group and/or a methacryloyl group, and a perfluoroalkylene group; and a compound (B) that...  
WO/2014/133041A1
An embodiment of the present invention relates to cellulose acylate film comprising a compound represented by general formula (I) and having a molar weight U of 515 or less, which is determined as the value obtained by dividing the molec...  
WO/2014/128992A1
Provided are: a (meth)acrylate, of which the sensitivity can be improved to thereby improve the curability thereof, has good compatibility with various acrylate compounds, does not undergo the increase in viscosity, and is free from the ...  
WO/2014/119234A1
The present invention provides a heat-curable resin which enables the production of a carbon-fiber-reinforced plastic having good workability and excellent mechanical properties by hand lay up (HUP) molding, resin transfer molding (RTM) ...  
WO/2014/112646A1
The present invention addresses the problem of providing a compound having a selective inhibitory activity on LAT-1 that can be expressed in a tumor cell at a high level. The present invention provides: a compound represented by formula ...  
WO/2014/112280A1
Provided are: a low-cost oily composition that is easily prepared, and additionally that has the combination of all of high safety with respect to living bodies and the environment, favorable thickening and gel-forming performance, a sup...  
WO/2014/103998A2
The objective of the present invention is to provide a tyrosine derivative which is useful as a melatonin receptor 1 MT1 antagonist, and a method for efficiently manufacturing a specific m-tyrosine derivative in which an iodine atom is i...  
WO/2014/095920A1
The present invention relates to novel compounds having β2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respirato...  
WO/2014/092161A1
The present invention addresses the problem of providing a method for producing an industrially-suitable carbamate compound without requiring a complicated operation, wherein a carbamate compound of a quality suitable for producing an is...  

Matches 451 - 500 out of 7,730